27 related articles for article (PubMed ID: 20734458)
1. Genetic overlap between autoimmune diseases and non-Hodgkin lymphoma subtypes.
Din L; Sheikh M; Kosaraju N; Smedby KE; Bernatsky S; Berndt SI; Skibola CF; Nieters A; Wang S; McKay JD; Cocco P; Maynadié M; Foretová L; Staines A; Mack TM; de Sanjosé S; Vyse TJ; Padyukov L; Monnereau A; Arslan AA; Moore A; Brooks-Wilson AR; Novak AJ; Glimelius B; Birmann BM; Link BK; Stewart C; Vajdic CM; Haioun C; Magnani C; Conti DV; Cox DG; Casabonne D; Albanes D; Kane E; Roman E; Muzi G; Salles G; Giles GG; Adami HO; Ghesquières H; De Vivo I; Clavel J; Cerhan JR; Spinelli JJ; Hofmann J; Vijai J; Curtin K; Costenbader KH; Onel K; Offit K; Teras LR; Morton L; Conde L; Miligi L; Melbye M; Ennas MG; Liebow M; Purdue MP; Glenn M; Southey MC; Din M; Rothman N; Camp NJ; Wong Doo N; Becker N; Pradhan N; Bracci PM; Boffetta P; Vineis P; Brennan P; Kraft P; Lan Q; Severson RK; Vermeulen RCH; Milne RL; Kaaks R; Travis RC; Weinstein SJ; Chanock SJ; Ansell SM; Slager SL; Zheng T; Zhang Y; Benavente Y; Taub Z; Madireddy L; Gourraud PA; Oksenberg JR; Cozen W; Hjalgrim H; Khankhanian P
Genet Epidemiol; 2019 Oct; 43(7):844-863. PubMed ID: 31407831
[TBL] [Abstract][Full Text] [Related]
2. Genetic susceptibility to diffuse large B-cell lymphoma in a pooled study of three Eastern Asian populations.
Bassig BA; Cerhan JR; Au WY; Kim HN; Sangrajrang S; Hu W; Tse J; Berndt S; Zheng T; Zhang H; Pornsopone P; Lee JJ; Kim HJ; Skibola CF; Vijai J; Burdette L; Yeager M; Brennan P; Shin MH; Liang R; Chanock S; Lan Q; Rothman N
Eur J Haematol; 2015 Nov; 95(5):442-8. PubMed ID: 25611436
[TBL] [Abstract][Full Text] [Related]
3. Impact of p53 arg72pro SNP on Breast Cancer Risk in North Indian Population.
Akhter N; Dar SA; Chattopadhyay S; Haque S; Anwer R; Wahid M; Jawed A; Lohani M; Mandal RK; Shukla NK; Abdul Y; Husain SA
Curr Genomics; 2018 Aug; 19(5):395-410. PubMed ID: 30065615
[TBL] [Abstract][Full Text] [Related]
4. TP53 Arg72 as a favorable prognostic factor for Chinese diffuse large B-cell lymphoma patients treated with CHOP.
Liu Y; Wang X; Ding N; Mi L; Ping L; Jin X; Li J; Xie Y; Ying Z; Liu W; Zhang C; Deng L; Song Y; Zhu J
BMC Cancer; 2017 Nov; 17(1):743. PubMed ID: 29126407
[TBL] [Abstract][Full Text] [Related]
5. The functional TP53 rs1042522 and MDM4 rs4245739 genetic variants contribute to Non-Hodgkin lymphoma risk.
Fan C; Wei J; Yuan C; Wang X; Jiang C; Zhou C; Yang M
PLoS One; 2014; 9(9):e107047. PubMed ID: 25203442
[TBL] [Abstract][Full Text] [Related]
6. p53 codon 72 polymorphism and hematological cancer risk: an update meta-analysis.
Weng Y; Lu L; Yuan G; Guo J; Zhang Z; Xie X; Chen G; Zhang J
PLoS One; 2012; 7(9):e45820. PubMed ID: 23029260
[TBL] [Abstract][Full Text] [Related]
7. Dysfunction of the TP53 tumor suppressor gene in lymphoid malignancies.
Xu-Monette ZY; Medeiros LJ; Li Y; Orlowski RZ; Andreeff M; Bueso-Ramos CE; Greiner TC; McDonnell TJ; Young KH
Blood; 2012 Apr; 119(16):3668-83. PubMed ID: 22275381
[TBL] [Abstract][Full Text] [Related]
8. Codeletion of CDKN2 and MTAP genes in a subset of non-Hodgkin's lymphoma may be associated with histologic transformation from low-grade to diffuse large-cell lymphoma.
Dreyling MH; Roulston D; Bohlander SK; Vardiman J; Olopade OI
Genes Chromosomes Cancer; 1998 May; 22(1):72-8. PubMed ID: 9591637
[TBL] [Abstract][Full Text] [Related]
9. The +252A/G polymorphism in the Lymphotoxin-α gene and the risk of non-Hodgkin lymphoma: a meta-analysis.
Cao C; Liu S; Lou SF; Liu T
Eur Rev Med Pharmacol Sci; 2014; 18(4):544-52. PubMed ID: 24610621
[TBL] [Abstract][Full Text] [Related]
10. Association with TP53 codon 72 polymorphism and the risk of non-Hodgkin lymphoma.
Kim HN; Yu L; Kim NY; Lee IK; Kim YK; Yang DH; Lee JJ; Shin MH; Park KS; Choi JS; Kim HJ
Am J Hematol; 2010 Oct; 85(10):822-4. PubMed ID: 20734458
[TBL] [Abstract][Full Text] [Related]
11. No association between the TP53 codon 72 polymorphism and risk or prognosis of Hodgkin and non-Hodgkin lymphoma.
Havranek O; Spacek M; Hubacek P; Mocikova H; Benesova K; Soucek P; Trneny M; Kleibl Z
Leuk Res; 2011 Aug; 35(8):1117-9. PubMed ID: 21546086
[TBL] [Abstract][Full Text] [Related]
12. Association between folate-metabolizing pathway polymorphism and non-Hodgkin lymphoma.
Kim HN; Lee IK; Kim YK; Tran HT; Yang DH; Lee JJ; Shin MH; Park KS; Shin MG; Choi JS; Kim HJ
Br J Haematol; 2008 Feb; 140(3):287-94. PubMed ID: 18042267
[TBL] [Abstract][Full Text] [Related]
13. [TP53 codon 72 polymorphism and gastric cancer risk: a case-control study in individuals from the central-western region of Venezuela].
Cañas M; Morán Y; Camargo ME; Rivero MB; Bohórquez A; Villegas V; Ramírez E; Rendón Y; Suárez A; Morales L; Useche E; Salazar S; Zambrano A; Ramírez A; Valderrama E; Briceño Z; Chiurillo MA
Invest Clin; 2009 Jun; 50(2):153-61. PubMed ID: 19662811
[TBL] [Abstract][Full Text] [Related]
14. Polymorphisms of drug-metabolizing genes and risk of non-Hodgkin lymphoma.
Kim HN; Kim NY; Yu L; Kim YK; Lee IK; Yang DH; Lee JJ; Shin MH; Park KS; Choi JS; Kim HJ
Am J Hematol; 2009 Dec; 84(12):821-5. PubMed ID: 19899130
[TBL] [Abstract][Full Text] [Related]
15. TP53 polymorphisms in gliomas from Indian patients: Study of codon 72 genotype, rs1642785, rs1800370 and 16 base pair insertion in intron-3.
Jha P; Jha P; Pathak P; Chosdol K; Suri V; Sharma MC; Kumar G; Singh M; Mahapatra AK; Sarkar C
Exp Mol Pathol; 2011 Apr; 90(2):167-72. PubMed ID: 21115003
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
